What has changed is our ability to address it in a way that is strategic, subtle, and informed by a deep understanding of facial anatomy and the aging process
Even in the United States, where several anti-obesity drugs have been approved, the prescription rates for these drugs are very low, and most cardiovascular guidelines still recommend lifestyle modifications as the only treatment for obesity to prevent ORCVDs [2,3,4]
Unfortunately, there's no easy answer
The drug in question goes beyond addressing GLP-1, with an effect closer to that of Wegovy
Fasting insulin levels fall substantially in most people within a few weeks of starting keto
[9] However, GLP-1 medications can delay gastric emptying such that food remains in the stomach beyond these fasting periods , potentially rendering standard fasting protocols insufficient